VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Last Price$484.20.8%
Market Cap$124.7B
LTM FCF to Net Income
147.6%
5Y avg
126.7%
Biotechnology industry median
84.2%
Stock quality & Intrinsic value
6/10
(0.3%) overvalued

Vertex Pharmaceuticals Incorporated FCF to Net Income

Annual
Quarterly
LTM
Industry median
Company stand-alone
VRTX
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
FCF to Net Income
93.0%
92.9%
26.5%
72.8%
56.2%
70.2%
89.2%
119.3%
(384.7%)
15.0%
76.0%
69.8%
(213.7%)
639.0%
56.3%
126.9%
110.4%
102.8%
118.2%
90.6%
VRTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for VRTX and see if it's the right time to invest.
Dive in

Vertex Pharmaceuticals Incorporated (VRTX) FCF to Net Income comparison analysis

Crunching data... Almost there!

VRTX key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Vertex Pharmaceuticals Incorporated's FCF to Net Income?

As of today, Microsoft Corp's last 12-month FCF to Net Income is 147.6%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for Vertex Pharmaceuticals Incorporated have been 129.8% over the past three years, and 133.0% over the past five years.

2) Is Vertex Pharmaceuticals Incorporated's FCF to Net Income Good?

As of today, Vertex Pharmaceuticals Incorporated's FCF to Net Income is 147.6%, which is higher than industry median of 84.2%. It indicates that Vertex Pharmaceuticals Incorporated's FCF to Net Income is Good.

3) How does Vertex Pharmaceuticals Incorporated's FCF to Net Income compare to its peers?

As of today, Vertex Pharmaceuticals Incorporated's FCF to Net Income is 147.6%, which is higher than peer median of 75.1%. The list of peers includes INCY, BGNE, ARGX, REGN, UTHR, NVO, SMMT, ALNY, BNTX, RPRX.